U.S. federal trademark · Serial No. 79339676 · Reg. No. 7135019
Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment
Scientific and medical research and development in the field of fibrosis, autoimmune diseases, and cancer; biotechnological research services in the field of fibrosis, autoimmune diseases, and cancer; providing scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancerous diseases; scientific advice relating to medicine
Medical analysis services for diagnosing cancer; RNA or DNA analysis for cancer diagnosis and prognosis; provision of medical information in the field of cancer prevention, screening, diagnosis and treatment; medical advice and information regarding pharmaceutical and medical products; medical testing
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.